ADMA Biologics Inc.

NASDAQ: ADMA · Real-Time Price · USD
16.95
-0.02 (-0.12%)
At close: Aug 15, 2025, 2:32 PM

ADMA Biologics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
426.45M 258.21M 154.08M 80.94M
Cost of Revenue
206.9M 169.27M 118.81M 79.77M
Gross Profit
219.55M 88.94M 35.27M 1.17M
Operating Income
138.98M 21.63M -39.37M -58.37M
Interest Income
2.1M 1.62M 44.83K 34.53K
Pretax Income
125.71M -28.24M -65.9M -71.65M
Net Income
197.67M -28.24M -85.18M -84.45M
Selling & General & Admin
74.12M 59.02M 52.46M 42.9M
Research & Development
1.81M 3.3M 3.61M 3.65M
Other Expenses
4.63M 4.99M 18.56M 13M
Operating Expenses
80.57M 67.31M 74.63M 59.55M
Interest Expense
13.93M 25.03M 19.28M 13.06M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
282.84M 236.58M 193.44M 139.32M
Income Tax Expense
-71.96M n/a 19.28M 12.81M
Shares Outstanding (Basic)
233.08M 223.98M 197.87M 139.58M
Shares Outstanding (Diluted)
243.34M 223.98M 197.87M 139.58M
EPS (Basic)
0.85 -0.13 -0.43 -0.61
EPS (Diluted)
0.81 -0.13 -0.43 -0.61
EBITDA
147.69M 5.12M -39.72M -53.33M
EBIT
139.64M -3.21M -46.63M -58.59M
Depreciation & Amortization
8.04M 8.33M 7.11M 5.5M